## Drug-Induced Lupus vs. Idiopathic SLE: Antibody Discrimination ### Pathophysiologic Distinction Drug-induced lupus (DIL) and idiopathic SLE share clinical overlap (arthritis, serositis, photosensitivity) but differ fundamentally in their immunogenic triggers and antibody profiles. DIL is caused by offending drugs (procainamide, hydralazine, isoniazid, TNF-α inhibitors) that alter self-antigens, triggering a T-cell-dependent response against histone-DNA complexes. ### Antibody Profile Comparison | Antibody | DIL | Idiopathic SLE | |----------|-----|----------------| | **Anti-histone** | 95%+ (hallmark) | 40–60% | | **Anti-dsDNA** | Rare (<5%) | 60–70% (disease-defining) | | **Anti-Smith (Sm)** | Absent | 20–30% (highly specific) | | **ANA** | Positive (usually diffuse) | Positive (95%+) | | **Anti-Ro/SSA, Anti-La/SSB** | Uncommon | 40–60% | | **Complement levels** | Normal or mildly reduced | Often low (C3, C4) | **Key Point:** Anti-histone antibodies are the **pathognomonic antibody of DIL**. The **absence of anti-dsDNA and anti-Smith** in the presence of **anti-histone positivity** strongly favors DIL over idiopathic SLE. ### Clinical Discriminators **High-Yield:** DIL typically: - Develops after weeks to months of drug exposure - Resolves within weeks to months of drug withdrawal - Spares the kidneys (no lupus nephritis) - Does NOT cause CNS involvement - Has normal or mildly reduced complement levels Idiopathic SLE: - Often presents in young women (peak 20–40 years) - Chronic, relapsing course - Frequently involves kidneys (lupus nephritis in 30–50%) - Can cause CNS manifestations (seizures, psychosis) - Often has low C3 and C4 (immune complex deposition) **Mnemonic: HISTONE-DIL** - **H**ydralazine → DIL - **I**soniazid → DIL - **S**ulfonamides → DIL (rare) - **T**NF-α inhibitors → DIL - **O**ther: procainamide, quinidine → DIL - **N**ormally anti-histone positive in DIL - **E**xtracts histone-DNA complexes (mechanism) ### Why Anti-Histone is the Gold Standard Anti-histone antibodies arise because offending drugs (especially procainamide and hydralazine) form **drug-histone complexes** that are recognized as foreign. This triggers a B-cell and T-cell response against the histone-DNA core. In contrast, idiopathic SLE develops from loss of tolerance to native nuclear antigens (dsDNA, Sm), which is reflected in the presence of anti-dsDNA and anti-Sm antibodies. **Clinical Pearl:** A patient with clinical lupus-like features, positive ANA, but **negative anti-dsDNA and anti-Sm with positive anti-histone** should prompt a careful drug history. Withdrawal of the offending agent typically results in resolution of symptoms and normalization of antibodies within weeks to months. [cite:Robbins 10e Ch 6; Harrison 21e Ch 280]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.